Wenatchee Valley Medical Center
Whole vs Partial Breast Irradiation for Stage 0, I, or II Breast Cancer (NSABP B-39)
A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women With Stage 0, I, or II Breast Cancer
Investigator: Tanya Wahl, MD; Conditions: Breast Cancer; Status: Recruiting; Study ID: NCT00103181
A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently With Radiation Therapy and Radiation Therapy Alone for Women With HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
Investigator: Tanya A. Wahl ; Conditions: Breast Cancer; Status: Recruiting; Study ID: NCT00769379
Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or Without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy
Investigator: Benjamin Greer, MD; Conditions: Cervical Cancer; Status: Recruiting; Study ID: NCT00980954
A Randomized Phase III Trialof Cisplatin and Tumor Volume Directional Irradiation Followed By Carboplatin and Paclitaxel Vs.for Optimally Debulked, Advanced Endometrial Carcinoma
Investigator: Benjamin Greer, MD; Conditions: Endometrial Cancer; Status: Recruiting; Study ID: NCT00942357
A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed By Paclitaxel/Carboplatin Chemotherapy in Patients With High Risk, Early Stage Endometrial Carcinoma
Investigator: Benjamin E. Greer, MD; Conditions: Endometrial Cancer, Fatigue, Neurotoxicity; Status: Recruiting; Study ID: NCT00807768
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination With Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreduction Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer
Investigator: Benjamin E. Greer, MD; Conditions: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer; Status: Recruiting; Study ID: NCT00565851
A Phase I/II Study of Fludarabine (F), Cyclophosphamide ©), Rituximab ®), and Vorinostat (V) Followed by RV Maintenance Therapy in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small LymphoCtic Lymphoma (SLL)
Investigator: John Pagel, MD, PhD; Conditions: Leukemia, Lymphoma; Status: Recruiting; Study ID: NCT00918723
Join Us On